CING: Nilai perusahaan marang bathi resik Cingulate

Simbol lan logo merek Cingulate (CING)

Cingulate Inc. enjoys a well-deserved reputation for developing advanced ADHD therapies. This price chart reflects the -2.20 metric, while production is based in Kansas centers utilizing external CDMO sites to optimize output. Business profitability relies on the sale of controlled-release products through insurance companies and pharmacies following FDA certification.

CING (Cingulate) riwayat Rasio rega marang bathi saka 04.07.2022 nganti 10.11.2026

Rincian metrik komprehensif lan analitis Cingulate Inc (CING)

- rega lan prakiraan konsensus rega:
Rega saham Cingulate Corp|CING - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Cingulate Inc.|CING - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku Saham Cingulate|CING - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku cingulate.com|CING - Gunggung Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Modal Cingulate Inc.|CING - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Cingulate Corp|CING - Gunggung utang perusahaan|Rasio utang marang aset resik Cingulate Inc.|CING - Utang jangka dawa perusahaan|Utang jangka cendhak Cingulate|Indikator likuiditas cepet cingulate.com
- indikator pendapatan resik lan kelipatan nilai:
CING - Bathi resik|Prakiraan bathi perusahaan Cingulate Inc.|CING - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Cingulate Corp|CING - Pangali PEG|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cingulate Inc.|CING - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Cingulate|CING - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cingulate.com|CING - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cingulate Inc.
Ringkesan analisis perusahaan:cingulate.com - CING
Produk asli Cingulate Inc.

For Cingulate Inc. (CING), with its highly scalable drug-delivery technologies for ADHD, it is critical to align the market value of shares with the business's actual ability to generate profit. By analyzing the current P/E multiple, an investor determines the capital payback period via net income, which allows for the identification of undervalued asset zones and the avoidance of purchasing overheated securities during periods of inflationary pressure.

Analisis perusahaan pesaing

Pangali P/E alkermes.com|Koefisien rega marang bathi AVDL (Avadel Pharmaceuticals plc)|ATAI (atai Life Sciences NV) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi GH Research Corp GHRS|MNMD (Mind Medicine Corp) - Kapitalisasi marang bathi resik|CMPS - Rasio rega marang bathi|Periode bali modal bisnis lbpharma.us LBRX|DRUG (Bright Minds Biosciences Inc.) - Koefisien rega marang bathi|Kapitalisasi marang bathi Vanda Pharma (VNDA)|CYBN (Cybin Inc) - Pangali P/E|Koefisien rega marang bathi Alto Neuroscience Corp (ANRO)|Pangali P/E NRXP|SILO (Silo Pharma Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi China Pharma Holdings, Inc. CPHI|clearmindmedicine.com (CMND) - Kapitalisasi marang bathi|Psyence Biomedical Limited - Pangali P/E|SciSparc Corp (SPRC) - Koefisien rega marang bathi|SEEL: Pangali P/E|VRPX - Periode bali modal bisnis|Rasio rega marang bathi Karuna Therapeutics, Inc.